Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | OMO-1 |
Trade Name | |
Synonyms | JNJ-38877618|OMO1 |
Drug Descriptions |
OMO-1 (JNJ-38877618) is a MET inhibitor that suppresses the kinase activity of wild-type and mutant MET, potentially resulting in reduced tumor growth (Cancer Res 2018;78(13 Suppl):Abstract nr 4791). |
DrugClasses | MET Inhibitor 59 |
CAS Registry Number | 943540-74-7 |
NCIT ID | C148537 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Erlotinib + OMO-1 | Erlotinib OMO-1 | 0 | 0 |
OMO-1 | OMO-1 | 0 | 1 |
OMO-1 + unspecified EGFR tyrosine kinase inhibitor | OMO-1 unspecified EGFR tyrosine kinase inhibitor | 0 | 1 |